Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
US Army
Queensland Health
Julphar
Federal Trade Commission
UBS
McKesson

Generated: May 26, 2018

DrugPatentWatch Database Preview

MECLOFENAMATE SODIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Meclofenamate Sodium patents expire, and when can generic versions of Meclofenamate Sodium launch?

Meclofenamate Sodium is a drug marketed by Am Therap, Barr, Fosun Pharma, Mylan, Par Pharm, Usl Pharma, Vitarine, Watson Labs, and Watson Labs Teva. and is included in nineteen NDAs.

The generic ingredient in MECLOFENAMATE SODIUM is meclofenamate sodium. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the meclofenamate sodium profile page.
Drug patent expirations by year for MECLOFENAMATE SODIUM
Synonyms for MECLOFENAMATE SODIUM
2-([2,6-Dichloro-3-methylphenyl]amino)benzoic acid sodium
2-(2,6-dichloro-3-methyl-anilino)benzoate
2-[(2,6-Dichloro-3-methylphenyl)-amino]benzoic acid
2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid sodium salt
2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid, sodium salt
6385-02-0
9MMQ0YER4E
AC1L1H9W
AC1Q1VOZ
AC1Q1VRG
AC1Q1VRH
AKOS009157878
Anthranilic acid, N-(2,6-dichloro-m-tolyl)-, monosodium salt
ANW-41178
Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium salt
Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium salt, monohydrate
C02996
C14H10Cl2NO2.Na
CCG-40117
CHEBI:6711
CHEMBL876
CI 583
CL-583
CL-583.NA SALT
CPD000058785
CTK5I4916
D08162
D0MN9K
DR001387
EINECS 228-983-3
EN300-51912
EU-0100727
FT-0603690
HMS2091B08
HMS2231H18
HMS3259F13
HMS3262A16
HMS3372D22
HMS3649O09
HMS3652L10
HMS501J06
I01-1145
Lopac-M-4531
LP00727
LS-20490
M 4531
M1269
MCULE-4652582072
MECLODIUM
Meclofenamate (sodium salt)
Meclofenamate sodium [USAN:USP]
Meclofenamate Sodium [USAN]
Meclofenamic acid sodium
Meclofenamic acid sodium salt
Meclomen
Meclomen (TN)
Meclonax
MFCD00077376
MLS000069578
MLS001056523
MLS001077271
MolPort-003-666-222
Monosodium N-(2,6-dichloro-m-tolyl)anthranilate
Monosodium N-(2,6-dichloro-m-tolyl)anthranilate monohydrate
Movens
N-(2,6-Dichloro-m-tolyl)anthranilic acid sodium salt
NC00649
NCGC00016169-01
NCGC00016169-02
NCGC00016169-03
NCGC00094073-01
NCGC00094073-02
NCGC00261412-01
NE43592
OGPIIGMUPMPMNT-UHFFFAOYSA-M
Opera_ID_596
OR113899
potassium 2-[(2,6-dichloro-3-methylphenyl)amino]benzoate
s4295
SAM002548942
SCHEMBL1649454
SMR000058785
Sodium 2-((2,6-dichloro-3-methylphenyl)amino)benzoate
sodium 2-(2,6-dichloro-3-methylanilino)benzoate
sodium 2-[(2,6-dichloro-3-methylphenyl)amino]benzoate
Sodium meclofenamate
sodium meclofenamate (anhydrous)
Sodium meclophenamate
ST51015053
Tox21_500727
UNII-9MMQ0YER4E

US Patents and Regulatory Information for MECLOFENAMATE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Therap MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071362-001 Feb 10, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 070401-001 Nov 25, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 071081-002 Sep 3, 1986 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 072809-001 Mar 20, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
US Department of Justice
Cerilliant
Federal Trade Commission
QuintilesIMS
US Army
Moodys
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.